“Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trial.”, Am J Ophthalmol, vol. 159, no. 4, pp. 659-666.e1, 2015.
, “Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants.”, Proc Natl Acad Sci U S A, vol. 103, no. 10, pp. 3896-901, 2006.
,